CRISPR/Cas9 for hepatitis B virus infection treatment

CRISPR/Cas9 for hepatitis B virus infection treatment

Abstract Hepatitis B virus (HBV) infection remains a global health challenge. Despite the availability of effective preventive vaccines, millions of people are at risk of cirrhosis and hepatocellular carcinoma. Current drug therapies inhibit viral replication, slow the progression of liver fibrosis...

Full description

Bibliographic Details
Main Authors: Bo Cai, Shixue Chang, Yuhan Tian, Shuai Zhen
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Immunity, Inflammation and Disease
Subjects:
cccDNA
CRISPR/Cas9
HBV
nanoparticles
Online Access:https://doi.org/10.1002/iid3.866

Similar Items

Similar Items